Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by OldRedon Jan 12, 2011 6:04am
248 Views
Post# 17958102

Partners

Partners

Partners

TFChem – Therapeutic Fluorine Chemistry

Is a company intent on discovery, innovation, development, commercialization of new and efficient therapeutic agents through novel utilization of Glycodrugs based on core technology of new fluorinated carbohydrate mimics.  Current therapeutic areas of interest are Metabolic Diseases: Diabetes and Obesity, Oncology and Inflammation.

www.tfchemistry.com

SignalChem

SignalChem is a biotechnology company focused on the research, development and production of innovative cell signaling products to advance basic research and drug discovery efforts, with specific emphasis on the production of highly purified biologically active human recombinant proteins.

Cellular signaling or the mechanism by which a cell transmits its signals inwards, ultimately producing a specific biological response, is of fundamental clinical importance. It is well documented that aberrations in these discrete pathways have been linked to the development of a variety of human diseases including cancer, cardiovascular disease, metabolic disorders, neurodegenerative disease and inflammatory conditions amongst others.

With the recent success of signal transduction inhibitors in the clinic, there is an intensive effort to identify ‘targets’ linked with the pathogenesis of a human disease and to develop selective molecules to perturb these ‘targets’ in an effort to improve patient prognosis and minimize the non-specific systemic side-effects associated with generalized treatment modalities.

The founders and scientific members of SignalChem have the knowledge to understand the architecture and biology of these discrete signaling pathways and to leverage this expertise to bring value-added products to the market. SignalChem is emerging as a leader and a key contender in the life science recombinant protein market place.

SignalChem’s core product areas include: active human protein kinases, active human protein phosphatases, unactive signaling proteins, assay kits and biologically relevant kinase and phosphatase substrates.

www.signalchem.com

Boughton Law Corporation
www.boughton.ca

BDO Dunwoody LLP – Chartered Accountants and Advisors
www.bdo.ca

Union Securities - Sponsor
www.union-securities.com

Bullboard Posts